Zhongnan Medical Journal Press

Home Results

A total of 4 result was found. Results that relate to Empagliflozin

Cost-utility analysis of sacubitril/valsartan, dapagliflozin and empagliflozin in heart failure with reduced ejection fraction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(8):878-885.
9845 times 2196 times

Dan-Dan LU Sheng-Xiang WANG Shan LU Dan PAN Li-Yuan SHI Fei-Chuang Jing2

Heart failure with reduced ejection fraction Sacubitril/valsartan Dapagliflozin Empagliflozin Markov model Cost-utility analysis
Details
Evaluation of the efficacy and safety of dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy based on real-world data

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):734-742.
17177 times 2494 times

HU Ruiwen JI Cheng LI Li

Diabetic nephropathy Dapagliflozin Empagliflozin Real world study Efficacy Safety
Details
Comprehensive clinical evaluation of empagliflozin in the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1127-1139.
9909 times 1951 times

ZHANG Bei XUE Qingxia CHEN Lu CHEN Jiaojiao ZHANG Huiyuan MU Shengjun SUN Fudong ZHAO Quan

Empagliflozin Dapagliflozin Type 2 diabetes mellitus Comprehensive clinical evaluation
Details
Clinical efficacy of Tianqi Jiangtang capsule combined with empagliflozin in newly diagnosed type 2 diabetes mellitus patients

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):765-772.
955 times 313 times

SHI Jin PEI Zijuan ZHANG Dan CHEN Dan WANG Dandan ZHANG Li SHI Kaiyue WANG Dan XIE Muya YAN Ying

Type 2 diabetes Tianqi Jiangtang capsules Empagliflozin Blood sugar Insulin
Details